← Back
$TBPH All transactions

Theravance Biopharma, Inc.

M 10b5-1 Plan

$ Value

$142K

Shares

14,000

Price

$10

Filed

Dec 1

Insider

Name

BROSHY ERAN

Title

CIK

0001256230

Roles

Director

Transaction Details

Transaction Date

2025-11-26

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

81,749

Footnotes

The reporting person exercised stock options to acquire 14,000 Ordinary Shares and sold all such shares on the same day in a broker-assisted transaction. No shares were withheld for taxes. The transactions reported on this Form 4 were effected pursuant to the reporting person's Rule 10b5-1 trading plan adopted on March 14, 2024. | The transactions reported on this Form 4 were effected pursuant to the reporting person's Rule 10b5-1 trading plan adopted on March 14, 2024. | This Share Option was fully vested and exercisable (having vested as to 1/12th of the shares subject to the option upon completion of each continuous month of service following the original grant date and any remaining unvested shares vesting on the date of the next annual meeting of the company's shareholders provided continuous service through such date). | Reflects solely exercisable, vested Share Options following reported transaction.

Filing Info

Accession No.

0001256230-25-000009

Form Type

4

Issuer CIK

0001583107

BROSHY ERAN's History

Date Ticker Type Value
2025-11-26 TBPH $280K
2025-11-26 TBPH $310K
2025-11-26 TBPH M $142K
2025-11-11 TBPH $546K
2025-11-11 TBPH $287K
2025-11-11 TBPH $264K
2025-11-11 TBPH $259K
2025-11-11 TBPH M $142K
2025-05-21 CERT M $0
2025-05-21 CERT M $0

Other Insiders at TBPH (90d)

Insider Bought Sold Last
Winningham Rick E
CHIEF EXECUTIVE OFFICER
2026-04-01
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
2026-04-01
Sawaf Aziz
SVP & CHIEF FINANCIAL OFFICER
2026-04-01
Grimaud Brett A.
SVP, GEN COUNSEL AND SECRETARY
2026-04-01